PRHC
NVO

P.R. Herzig & Co’s Novo Nordisk NVO Stock Holding History

P.R. Herzig & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-31,200
Closed -$649K – 50
2016
Q3 		$649K Buy
31,200
+15,600
+100% +$387K 1.27% 30
2016
Q2 		$419K Hold
15,600
– – 0.88% 34
2016
Q1 		$423K Hold
15,600
– – 0.93% 37
2015
Q4 		$453K Buy
+15,600
New +$432K 1.09% 35
2015
Q3 		– Sell
-12,400
Closed -$340K – 48
2015
Q2 		$340K Buy
+12,400
New +$349K 0.69% 43

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

P.R. Herzig & Co's NVO Position: Q4 2016 in Review

P.R. Herzig & Co sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 31,200 shares — an estimated $649K sold.

P.R. Herzig & Co first reported a position in NVO in Q2 2015 and held it in 5 quarters. The position peaked at $649K in Q3 2016. 482 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • P.R. Herzig & Co reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • P.R. Herzig & Co sold 31,200 Novo Nordisk shares in Q4 2016, an estimated $649K.
  • P.R. Herzig & Co first reported a position in Novo Nordisk in Q2 2015 and held it in 5 quarters.
  • P.R. Herzig & Co's Novo Nordisk position peaked at $649K in Q3 2016.
  • 482 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on P.R. Herzig & Co's 13F filing for Q4 2016, filed 13 Jan 2017.